O documento discute o tratamento da Covid-19 leve/moderada, comparando a abordagem de "tratamento precoce" versus a medicina baseada em evidências. Defende que apenas medicamentos com comprovação científica de eficácia devem ser usados no tratamento ambulatorial, como alguns anticorpos monoclonais em casos selecionados. Critica o uso de medicações sem eficácia comprovada ou com riscos, como a cloroquina/hidroxicloroquina.
This document discusses strategies for writing and publishing case reports. It provides tips for determining if a case is suitable for publication, how to structure a case report paper, and which journals may be appropriate targets for submission. The key points covered include focusing on cases that teach an important lesson or further clinical understanding, rather than simply describing another example of a known condition. Highlighting either a rare presentation of a common disease or a common presentation of a rare disease can make a case report more novel and interesting. Structuring the paper with an introduction that provides context, followed by a case description and discussion of take-home messages is recommended. Factors like journal impact factor, open access fees, and searchability on PubMed should also be
O documento discute o tratamento da Covid-19 leve/moderada, comparando a abordagem de "tratamento precoce" versus a medicina baseada em evidências. Defende que apenas medicamentos com comprovação científica de eficácia devem ser usados no tratamento ambulatorial, como alguns anticorpos monoclonais em casos selecionados. Critica o uso de medicações sem eficácia comprovada ou com riscos, como a cloroquina/hidroxicloroquina.
This document discusses strategies for writing and publishing case reports. It provides tips for determining if a case is suitable for publication, how to structure a case report paper, and which journals may be appropriate targets for submission. The key points covered include focusing on cases that teach an important lesson or further clinical understanding, rather than simply describing another example of a known condition. Highlighting either a rare presentation of a common disease or a common presentation of a rare disease can make a case report more novel and interesting. Structuring the paper with an introduction that provides context, followed by a case description and discussion of take-home messages is recommended. Factors like journal impact factor, open access fees, and searchability on PubMed should also be
6. なぜか?
• バンコマイシン vs. テイコプラニン
ダプトマイシン
リネゾリド 他
基本的に非劣勢試験
バンコマイシンが標準治療
Thomas L. Holland et al. JAMA. 2014;312(13):1330-41.
Catherine Liu et al. Clinical Infectious Diseases 2011;52(3):e18–e55